VEGF 936 C/T gene polymorphism in renal transplant recipients: Association of the T allele with good graft outcome

Human Immunology

Volumn 68, Issue 7, 2007, Pages 599-602

  Günesacar, Ramazan ^a   Opelz, Gerhard ^b   Erken, Eren ^a   Pelzl, Steffen ^b   Döhler, Bernd ^b   Ruhenstroth, Andrea ^b   Süsal, Caner ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gene polymorphism; Graft outcome; Renal transplantation; VEGF

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOSINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMINE; VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 34250307554     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.03.015     Document Type: Article

References (20)

1. Abbas A.K., and Lichtman A.H. Cellular and Molecular Immunology (2003), WB Saunders Co, Philadelphia
2. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 (1999) 527
3. Ferrara N., and Gerber H.P. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 106 (2001) 148
4. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9
5. Zachary I., and Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49 (2001) 568
6. Mor F., Quintana F.J., and Cohen I.R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172 (2004) 4618
7. Detmar M., Brown L.F., Schon M.P., Elicker B.M., Velasco P., Richard L., Fukumura D., Monsky W., Claffey K.P., and Jain R.K. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 11 (1998) 1
8. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., and Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1991) 11947
9. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., and Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60 (1999) 1245
10. Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12 (2000) 1232
11. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., and Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37 (2000) 443
12. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Sawa T., Takata N., and Katayama S. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 (2002) 1635
13. Shahbazi M., Fryer A.A., Pravica V., Brogan I.J., Ramsay H.M., Hutchinson I.V., and Harden P.N. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13 (2002) 260
14. Lemos F.B., Mol W.M., Roodnat J.I., Uitterlinden A., Ijzermans Z.N., Weimar W., and Baan J.J. The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation. Transplantation 79 (2005) 1221
15. Krippl P., Langsenlehner U., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., Paulweber B., Weitzer W., and Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106 (2003) 468
16. Pawlik A., Domanski L., Rozanski J., Florczak M., Dabrowska-Zamojcin E., Dutkiewicz G., and Gawronska-Szklarz B. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection. Transplant Proc 37 (2005) 2041
17. Cohen I.R. Discrimination and dialogue in the immune system. Semin Immunol 12 (2000) 215
18. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., and Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276 (2001) 7614
19. Sankaran D., Asderakis A., Ashraf S., Roberts I.S., Short C.D., Dyer P.A., Sinnott P.J., and Hutchinson I.V. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56 (1999) 281
20. Mytilineos J., Laux G., and Opelz G. Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha gene polymorphisms in kidney transplantation: a collaborative transplant study report. Am J Transplant 4 (2004) 1684